[ACX2024] Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
Mini
0
Jan 2
50%
chance
1D
1W
1M
ALL
Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
Resolves the same as the original on Metaculus.
Resolution criteria
This question will resolve as Yes if either the US Food and Drug Administration or the European Medicines Agency withdraw approval for semaglutide (AKA Wegovy, Ozempic, or any other brand name for semaglutide) before January 1, 2025. The stated reason for withdrawal must include concerns of safety or harmful side effects.
Fine print and additional background information can be found on Metaculus.
Once the original resolves, its resolution will be applied to this market automatically. Trustworthy-ish users are encouraged to resolve this market before then if the outcome is known and unambiguous. Feel free to ping @jskf to request early resolution or to report issues.
Get Ṁ1,000 play money
Related questions
Related questions
Will US govt not renew the ban on funding gain-of-function research in 2022?
34% chance
Will there be a new COVID variant with an impact greater than Omicron in 2022 or 2023?
46% chance
"Will a new version of COVID be substantially able to escape Omicron vaccines in 2023?"
44% chance
Will I finish the task before 2024?
59% chance
Will I finish the task by 2024?
50% chance
Will the test results be conclusive by the end of the year?
50% chance
Will I eat a cake in 2023?
50% chance
Will I finish the task before 2024?
50% chance
[Kalshi] Will the CDC identify a new variant of concern by December 31, 2023?
50% chance
Will any Chinese semiconductor firm announce a new product with specifications past the threshold of US export controls by the end of 2023?
50% chance